GA-AGCO
13.12.2022 14:31:37 CET | Business Wire | Press release
AGCO Corporation (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, received ten AE50 Awards from the American Society of Agricultural and Biological Engineers (ASABE) for 2023. Each year, an international panel of engineering experts recognizes the year’s 50 most innovative designs in engineering products or systems for the food and agriculture industries. AGCO’s ten AE50 awards span the company’s strong brand portfolio, including Fendt, Fuse, Intelligent Ag, Massey Ferguson, and Precision Planting.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221213005076/en/
AGCO Corp. won ten 2023 AE50 Awards from ASABE for innovative design in engineering products or systems for agriculture. AGCO’s awards span the company’s strong brand portfolio, including Fendt, Fuse, Intelligent Ag, Massey Ferguson, and Precision Planting. Pictured above are the AE50 Award-winning Massey Ferguson WR Series Windrower and Fendt 700 Gen7 Vario tractor.(Photo: Business Wire)
“Innovation is core to our vision of being farmers’ most trusted partner for industry-leading, smart farming solutions and we’re honored to be recognized with ten AE50 Awards across our brand portfolio,” said Eric Hansotia, AGCO chairman, president, and chief executive officer. “Helping farmers maximize yield while reducing inputs and impact delivers real value to farmers and motivates our team to accelerate the pace of farmer-first innovation in every area of our business.”
The Fendt® 700 Gen7 Vario® is the brand’s most popular workhorse tractor. Redesigned to improve performance, reduce costs, and increase productivity, the tractor is one of the most versatile and operator-friendly tractors in its market segment with five models ranging from 203 to 283 engine hp, a standard VarioDrive™ CVT, FendtONE™ operators’ station, fuel-efficient AGCO Power™ 7.5L engine, and agronomic-boosting features such as the VarioGrip™ Central Tire Inflation System (CTIS).
Geo-Bird® from Fuse® is a free and intuitive web app that automatically optimizes waylines for multiple fields and implements, saving farmers time and money and supporting greater sustainability. Controlled Traffic Farming (CTF) waylines help farmers reduce time and cost requirements; turns, wheel traffic, and headland overlap; fuel usage and CO2 footprints; and yield-robbing soil compaction. Geo-Bird’s waylines are exportable to terminals of multiple brands for greater ease of use across disparate operations.
The Pit Level Monitor Model AP-6010 from AP (Automated Production®) uses electronic pressure transducers to efficiently measure effluent depth in manure pits below swine confinement facilities. This innovation provides swine facility operators with more accurate management information regarding manure pits, including early warnings of water leakage and remaining storage capacities.
The Massey Ferguson® LB2200 Series Large Square Baler merges the reliability of previous models with new cutting-edge technology advancements. A new pickup design improves baler feeding and parts reliability, while also reducing noise. New axle and tire offerings with a single bogie suspension improve ground clearance and rideability. Common Electric Architecture (CEA) provides greater information and control via ISOBUS terminal for Tractor Implement Management (TIM), bale length, bale eject, and bale chute fold.
The Massey Ferguson® WR Series Windrower provides up to 282 peak horsepower and an industry-exclusive closed-center hydraulic system for increased fuel efficiency and available header horsepower. This also eliminates the need for a secondary pump for auxiliary functions such as a triple windrow attachment (TWA). Technology updates improve field efficiency, reduce operator stress, and allow real-time tracking and data management. MF Guide ensures accurate auto-steering to minimize pass-to-pass overlap. Optional rear steer is available for road transport speeds up to 24.5 mph.
Recon SpraySense™ from Intelligent Ag™ is a retrofit sprayer product that measures pressure and flow at each nozzle to help ensure applications match targeted coverage and rates. GPS capability and a database of nozzles from major manufacturers infer accurate droplet size. Each nozzle’s performance is condensed as a single Spray Quality Score and provided to operators via an iPad application. Recon SpraySense is a turn-key solution and provides state-of-the-art technology on sprayers old and new.
ReClaim™ from Precision Planting® replaces nozzle bar endcaps in sprayers and provides a return path back to the tank for improved product agitation and circulation, faster boom priming, and improved boom cleanout. ReClaim also improves sprayer cleanout with compressed air that pushes product back to the tank where it is drained and properly disposed. These improvements reduce build-up in the boom, product waste on the ground, and crop damage from misapplication.
Precision Planting’s Radicle Agronomics™ is the world’s first, fully-automated soil laboratory. Its small footprint, self-calibration technology, and ability to run hundreds of unattended samples, replaces manual, error-prone processes and provides tremendous efficiency and improved accuracy to professional agronomists. Cloud-based software connects all steps of the field-to-lab process so agronomists can deliver superior nutrient management recommendations to their clients.
Precision Planting’s EM HD is a new liquid fertilizer controller and sensor that uses an electromagnetic flow sensor to provide row-by-row, high-speed liquid fertilizer rate control on row crop planters, side-dress implements, and strip-till implements. Immediate feedback from the flow sensor allows the system to make high-speed changes to the liquid valve control, which maintains a more accurate and consistent flow of fertilizer to the implement’s application point.
Precision Planting’s Blockage Expansion Module (BXM) is a monitoring component for non-singulated crop seeding implements that combines and connects multiple blockage sensors into a single connection point for 20|20 seed monitoring systems. By simplifying the implement’s electronic components and providing more user-friendly and actionable data, BXM improves the growers' ability to diagnose issues arising in the delivery of products from the commodity tanks to the application point.
For more information on these AE50 award-winning products, visit your nearest AGCO dealer, the links above, or AGCOcorp.com.
Online Version
An online version of this announcement with media downloads is available HERE.
Fendt, Fuse, Geo-Bird, Massey Ferguson, Precision Planting, and Vario are registered trademarks of AGCO. AGCO Power, FendtONE, Intelligent Ag, Radicle Agronomics, Recon SpraySense, VarioDrive, and VarioGrip are trademarks of AGCO.
About AGCO
AGCO (NYSE:AGCO) is a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology. AGCO delivers customer value through its differentiated brand portfolio including core brands like Challenger®, Fendt®, GSI®, Massey Ferguson®, Precision Planting® and Valtra®. Powered by Fuse® smart farming solutions, AGCO’s full line of equipment and services help farmers sustainably feed our world. Founded in 1990 and headquartered in Duluth, Georgia, USA, AGCO had net sales of approximately $11.1 billion in 2021. For more information, visit www.AGCOcorp.com. For company news, information and events, please follow us on Twitter: @AGCOCorp. For financial news on Twitter, please follow the hashtag #AGCOIR.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221213005076/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Doubtless Pet Care Launches to Provide Peace of Mind to Pet Parents and Help Their Pets Live Happier, Healthier Lives29.6.2026 10:15:00 CEST | Press release
Doubtless combines industry-leading pet insurance with innovative care solutions, protecting more than 6 million pets across 10 global markets Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associated with having a pet should never keep families from experiencing the joy of a life with pets,” said Dirk Beeckman, CEO of Doubtless. “By harnessing the power of our international footprint, we are building on our leadership in pet insurance to create a global suite of solutions for pet parents, veterinarians and industry partners that makes pet care easie
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release
Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release
Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom